title: Term pregnancy: a period of heterogeneous risk for infant mortality.
abstract: OBJECTIVE
  To estimate the trend of maternal racial and ethnic differences in mortality for early-term (37 0/7 to 38 6/7 weeks of gestation) compared with full-term births (39 0/7 to 41 6/7 weeks of gestation).
  
  
  METHODS
  We analyzed 46,329,018 singleton live births using the National Center for Health Statistics U.S. period-linked birth and infant death data from 1995 to 2006. Infant mortality rates, neonatal mortality rates, and postneonatal mortality rates were calculated according to gestational age, race and ethnicity, and cause of death.
  
  
  RESULTS
  Overall, infant mortality rates have decreased for early-term and full-term births between 1995 and 2006. At 37 weeks of gestation, Hispanics had the greatest decline in infant mortality rates (35.4%; 4.8 per 1,000 to 3.1 per 1,000) followed by 22.4% for whites (4.9 per 1,000 to 3.8 per 1,000); blacks had the smallest decline (6.8%; 5.9 per 1,000 to 5.5 per 1,000) as a result of a stagnant neonatal mortality rate. At 37 weeks compared with 40 weeks of gestation, neonatal mortality rates increase. For Hispanics, the relative risk is 2.6 (95% confidence interval [CI] 2.0-3.3); for whites, the relative risk is 2.6 (95% CI 2.2-3.1); and for blacks, the relative risk is 2.9 (95% CI 2.2-3.8). Neonatal mortality rates are still increased at 38 weeks of gestation. At both early- and full-term gestations, neonatal mortality rates for blacks are 40% higher than for whites and postneonatal mortality rates 80% higher, whereas Hispanics have a reduced postneonatal mortality rate when compared with whites.
  
  
  CONCLUSIONS
  Early-term births are associated with higher neonatal, postneonatal, and infant mortality rates compared with full-term births with concerning racial and ethnic disparity in rates and trends.
authors: From the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland; the March of Dimes, White Plains, New York; and the U.S. Food and Drug Administration, Silver Spring, Maryland.
authors: Uma M
authors: UM
authors: Reddy
authors: Vani R
authors: VR
authors: Bettegowda
authors: Todd
authors: T
authors: Dias
authors: Tomoko
authors: T
authors: Yamada-Kushnir
authors: Chia-Wen
authors: CW
authors: Ko
authors: Marian
authors: M
authors: Willinger
references: Public Health Rep. 2001 Jan-Feb;116(1):15-21
references: 11571404
references: Matern Child Health J. 2002 Sep;6(3):169-79
references: 12236664
references: Am J Obstet Gynecol. 2008 Jan;198(1):51.e1-9
references: 17870043
references: Natl Vital Stat Rep. 2005 Mar 7;53(17):1-89
references: 15786629
references: Am J Obstet Gynecol. 2005 Jul;193(1):125-34
references: 16021070
references: Obstet Gynecol. 2010 Jul;116(1):136-139
references: 20567179
references: Am J Obstet Gynecol. 2010 Jul;203(1):58.e1-5
references: 20417495
references: Pediatrics. 2007 Mar;119(3):e659-65
references: 17332185
references: Am J Epidemiol. 1993 Apr 1;137(7):758-68
references: 8484367
references: Natl Vital Stat Rep. 2010 Apr 30;58(17):1-31
references: 20815136
references: J Pediatr. 2009 Mar;154(3):358-62, 362.e1
references: 18950794
references: Obstet Gynecol. 2009 Dec;114(6):1254-1258
references: 19935027
references: Vital Health Stat 2. 1982 May;(93):1-11
references: 7112964